Login to Your Account



Rusnano Bets $94.5M on 2 U.S. Nanomedicine Firms

By Nuala Moran
BioWorld International Correspondent

Wednesday, November 2, 2011

LONDON – Russia's state-owned investment firm Rusnano has made its first foray into U.S. biotech, joining existing and other new investors in private funding rounds totaling $94.5 million for nanomedicine specialists Selecta Biosciences Inc. and Bind Biosciences Inc.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription